 |
FDA approves less-invasive heart defibrillator
|
FDA approves less-invasive heart defibrillator
New device uses wires that sit just below skin's surface and do not need to be threaded through heart's blood vessels
September 30, 2012
The Associated Press
WASHINGTON — The Food and Drug Administration says it has approved a
first-of-a-kind heart-zapping implant from Boston Scientific that that
does not directly touch the heart.
Implantable defibrillators use thin wires to send electrical signals
that disrupt dangerous heart rhythms. Surgeons have traditionally
connected the wires to the heart through a blood vessel in the upper
chest.
The new device from Boston Scientific uses wires that sit just below the skin's surface and do not need to be threaded through the heart's blood vessels.
Natick, Mass.-based Boston Scientific Corp. acquired the device through a
$150 million buyout of San Clemente, Calif.-based Cameron Health. Under
the terms of the deal, Boston Scientific will pay an additional $150
million for FDA approval, plus up to $1 billion in payments based on
future sales figures.
Copyright 2012 Associated Press. All rights reserved. This
material may not be published, broadcast, rewritten, or redistributed.
No comments:
Post a Comment